Jonathan Cohen, MD
Otolaryngology · New Providence, NJNPI 1497915292
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Smith+Nephew at 38.0% of the total. Reporting peaked in 2022 at $1,829 and has fallen 83.5% since, to $303 in 2024.
Across 69 payments — averaging $59.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Medical Device Business Services, Inc.$815
- Intersect ENT, Inc.$280
- GSK$280
- Regeneron Healthcare Solutions, Inc.$267
- Aerin Medical Inc.$235
- plus $676 from 8 others
What the payments were for
- Travel & lodging$2,00249%
- Food & beverage$2,11751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $1,566 |
| Medical Device Business Services, Inc. | 1 | $815 |
| Intersect ENT, Inc. | 4 | $280 |
| GSK | 11 | $280 |
| Regeneron Healthcare Solutions, Inc. | 11 | $267 |
| Aerin Medical Inc. | 9 | $235 |
| Optinose US, Inc. | 11 | $218 |
| Stryker | 2 | $152 |
| Acclarent, Inc | 2 | $111 |
| Sanofi | 5 | $91 |
| Covis Pharma GmbH | 4 | $58 |
| Medtronic | 1 | $17 |
| Novartis | 1 | $15 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,120 in reported general payments places this provider in the 85th percentile of 232 otolaryngology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 236 | $4,406 |
| Azelastine Hcl | 74 | $3,049 |
| Famotidine | 88 | $2,384 |
| Ipratropium Bromide | 30 | $609 |
| Omeprazole | 21 | $497 |
| Fluocinolone Acetonide Oil | 11 | $414 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $140 |
| Prednisone | 22 | $37 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New Providence
- Suhyla AlamNew Providence$3K
- Nishant ReddyEast Windsor$133K
- Giant LinFlorham Park$25K
- Samir ShahVoorhees$16K
- Brian BensonHackensack$14K
- Andrew BlitzerHackensack$9K
- Ahmad MahmoudClifton$9K
- Jean EloyNewark$8K
- Ramtin KassirWayne$8K
- Wayne HsuehNewark$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.